Lycopodium Limited
LYOPF · OTC
6/30/2025 | 12/30/2024 | 6/30/2024 | 12/30/2023 | |
|---|---|---|---|---|
| Revenue | $168,045 | $165,891 | $169,730 | $174,819 |
| % Growth | 1.3% | -2.3% | -2.9% | – |
| Cost of Goods Sold | -$88,668 | $114,913 | $134,429 | $130,173 |
| Gross Profit | $256,713 | $50,978 | $35,301 | $44,647 |
| % Margin | 152.8% | 30.7% | 20.8% | 25.5% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $146,034 | $0 | $0 | $0 |
| SG&A Expenses | $144,310 | $1,724 | $12,476 | $12,344 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $108,543 | $0 | -$3,378 | -$5,321 |
| Operating Expenses | $252,853 | $1,724 | $9,097 | $7,023 |
| Operating Income | $3,861 | $49,253 | $26,204 | $37,623 |
| % Margin | 2.3% | 29.7% | 15.4% | 21.5% |
| Other Income/Exp. Net | $20,830 | -$13,439 | $2,087 | $1,309 |
| Pre-Tax Income | $24,690 | $35,815 | $28,291 | $38,932 |
| Tax Expense | $7,538 | $10,488 | $8,705 | $10,098 |
| Net Income | $16,969 | $25,249 | $20,748 | $29,966 |
| % Margin | 10.1% | 15.2% | 12.2% | 17.1% |
| EPS | 0.42 | 0.64 | 0.53 | 0.77 |
| % Growth | -34.4% | 20.8% | -31.2% | – |
| EPS Diluted | 0.42 | 0.64 | 0.53 | 0.77 |
| Weighted Avg Shares Out | 39,740 | 39,762 | 39,052 | 39,102 |
| Weighted Avg Shares Out Dil | 39,740 | 39,762 | 39,052 | 39,102 |
| Supplemental Information | – | – | – | – |
| Interest Income | $2,431 | $1,112 | $1,704 | $1,725 |
| Interest Expense | $370 | $0 | $344 | $417 |
| Depreciation & Amortization | $3,638 | $3,307 | $3,183 | $3,388 |
| EBITDA | $30,138 | $37,682 | $31,821 | $42,737 |
| % Margin | 17.9% | 22.7% | 18.7% | 24.4% |